Zaloguj się

Gotowe bibliografie tematyczne / Tolérance des lymphocytes T / Artykuły w czasopismach

Artykuły w czasopismach na temat „Tolérance des lymphocytes T”

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Tolérance des lymphocytes T.

Autor: Grafiati

Data publikacji: 18 maja 2024

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Tolérance des lymphocytes T”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Bonnefoy, Nathalie, Daniel Olive i Bernard Vanhove. "Les futures générations d’anticorps modulateurs des points de contrôle de la réponse immunitaire". médecine/sciences 35, nr 12 (grudzień 2019): 966–74. http://dx.doi.org/10.1051/medsci/2019193.

Pełny tekst źródła

Streszczenie:

Les points de contrôle du système immunitaire sont des systèmes moléculaires qui complètent les processus déclenchés par la reconnaissance antigénique en contrôlant l’inhibition ou l’activation des lymphocytes et des cellules myéloïdes, notamment celle des lymphocytes T régulateurs (Treg), permettant ainsi de combiner réponses immunes et maintien de la tolérance au soi. En cancérologie, l’inhibition de points de contrôle inhibiteurs vise à amplifier les réponses immunitaires existantes dirigées contre les tumeurs. Parmi ces points de contrôle inhibiteurs, dont des antagonistes sont en utilisation clinique, se trouvent CTLA-4 (cytolytic T-lymphocyte-associated antigen 4 ou CD152), PD-1 (programmed cell death 1, ou CD279), PD-L1 (programmed cell death-ligand 1, ou CD274), LAG-3 (Lymphocyte-activation gene 3, ou CD223), TIM3 (T-cell immunoglobulin and mucin-domain containing-3), TIGIT (T cell immunoreceptor with Ig and ITIM domains), VISTA (V-domain Ig suppressor of T cell activation), ou B7/H3 (ou CD276). La stimulation de points de contrôle activateurs tels que les molécules de co-activation CD28, CD137 (aussi appelé 4-1BB), OX40 [aussi appelé tumor necrosis factor receptor superfamily, member 4 (TNFRSF4)], GITR (Glucocorticoid-induced tumor necrosis factor receptor family-related protein) ou CD40, est également testée en cancérologie, le plus souvent en combinaison avec un antagoniste de point de contrôle inhibiteur. Dans les maladies auto-immunes et inflammatoires, des antagonistes de points de contrôle activateurs (CD28, CD40) et des agonistes de points de contrôle inhibiteurs (LAG-3) sont également à l’essai. Dans cette revue, nous mettons l’accent sur certains modulateurs de points de contrôle pour lesquels le mécanisme d’action a été particulièrement étudié. Cette description ne pouvant être exhaustive, nous avons regroupé dans le Tableau I l’ensemble des anticorps monoclonaux (AcM) ou protéines recombinantes en usage clinique à notre connaissance, modulant l’action d’un point de contrôle du système immunitaire.

Style APA, Harvard, Vancouver, ISO itp.

2

Hequet, Olivier, Marc Vocanson, Aurélie Guironnet-paquet, Audrey Nosbaum i Jean-François Nicolas. "Les lymphocytes T CD8+ suppresseurs jouent un rôle majeur dans la tolérance immunitaire induite par la photochimiothérapie extracorporelle". Annales de Dermatologie et de Vénéréologie 143, nr 12 (grudzień 2016): S426. http://dx.doi.org/10.1016/j.annder.2016.09.066.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Ochoa, Juan B., i Valeriya Makarenkova. "T lymphocytes". Critical Care Medicine 33, Suppl (grudzień 2005): S510—S513. http://dx.doi.org/10.1097/01.ccm.0000186788.71460.53.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

Fabbri, M. "T lymphocytes". International Journal of Biochemistry & Cell Biology 35, nr 7 (lipiec 2003): 1004–8. http://dx.doi.org/10.1016/s1357-2725(03)00037-2.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Lotteau, V. "La période de tolérance néonatale existe-t-elle ?" médecine/sciences 12, nr 8-9 (1996): 983. http://dx.doi.org/10.4267/10608/859.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

Robijn, R. J., T. Logtenberg, L. J. J. M. Wiegman, G. P. Van Berge Henegouwen, R. W. Houwen i J. C. Koningsberger. "Intestinal T Lymphocytes". Scandinavian Journal of Gastroenterology 30, sup212 (styczeń 1995): 23–33. http://dx.doi.org/10.3109/00365529509090298.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Degos, L. "Les lymphocytes T". médecine/sciences 3, nr 4 (1987): 229. http://dx.doi.org/10.4267/10608/3665.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

&NA;. "Cytotoxic T lymphocytes". Reactions Weekly &NA;, nr 1085 (styczeń 2006): 12–13. http://dx.doi.org/10.2165/00128415-200610850-00037.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

MARTIN, STEPHEN, ED CANTIN i BARRY T. ROUSE. "Cytotoxic T Lymphocytes." Annals of the New York Academy of Sciences 532, nr 1 Cytotoxic T C (sierpień 1988): 257–72. http://dx.doi.org/10.1111/j.1749-6632.1988.tb36344.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Langelot, M., K. Botturi-Cavaillès, D. Lair, F. Wessel, P. Germaud, A. Pipet i A. Magnan. "Lymphocytes T régulateurs". Revue Française d'Allergologie 50, nr 3 (kwiecień 2010): 98–101. http://dx.doi.org/10.1016/j.reval.2010.02.015.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

Aubin, F., i Ph Saas. "Lymphocytes T régulateurs". Annales de Dermatologie et de Vénéréologie 134, nr 2 (luty 2007): 167–72. http://dx.doi.org/10.1016/s0151-9638(07)91612-9.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

Ashton-Rickardt, P. G., i J. T. Opferman. "Memory T lymphocytes". Cellular and Molecular Life Sciences (CMLS) 56, nr 1-2 (1.10.1999): 69–77. http://dx.doi.org/10.1007/s000180050007.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

13

Guichard, Pierre. "L'Andalousie a-t-elle été un paradis de tolérance ?" Les Grands Dossiers des Sciences Humaines N° Hors-série, HS5 (1.02.2017): 60–61. http://dx.doi.org/10.3917/gdsh.hs5.0060.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

BAGOT, M., M. NIKOLOVA, F. SCHIRM-CHABANETTE, J. WECHSLER, L. BOUMSELL i A. BENSUSSAN. "Crosstalk between Tumor T Lymphocytes and Reactive T Lymphocytes in Cutaneous T Cell Lymphomas". Annals of the New York Academy of Sciences 941, nr 1 (25.01.2006): 31–38. http://dx.doi.org/10.1111/j.1749-6632.2001.tb03708.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

Hayward, Anthony R. "T-Lymphocytes: An Update". Pediatric Annals 16, nr 5 (1.05.1987): 391–94. http://dx.doi.org/10.3928/0090-4481-19870501-06.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

Smyth, Mark J., Michael H. Kershaw i Joseph A. Trapani. "XENOSPECIFIC CYTOTOXIC T LYMPHOCYTES". Transplantation 63, nr 8 (kwiecień 1997): 1171–78. http://dx.doi.org/10.1097/00007890-199704270-00019.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Bouladoux, Nicolas, Timothy W. Hand, Shruti Naik i Yasmine Belkaid. "Microbiote et lymphocytes T". médecine/sciences 29, nr 4 (kwiecień 2013): 349–52. http://dx.doi.org/10.1051/medsci/2013294005.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

Rouers, Angeline, Raphaël Jeger-Madiot, Arnaud Moris i Stéphanie Graff-Dubois. "Lymphocytes T folliculaireshelperet VIH". médecine/sciences 33, nr 10 (październik 2017): 878–86. http://dx.doi.org/10.1051/medsci/20173310020.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

Hamid, Qutayba. "T Lymphocytes in Asthma". Allergy & Clinical Immunology International - Journal of the World Allergy Organization 11, nr 5 (1999): 0192–94. http://dx.doi.org/10.1027/0838-1925.11.5.192.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

Ward, Stephen G., Kevin Bacon i John Westwick. "Chemokines and T Lymphocytes". Immunity 9, nr 1 (lipiec 1998): 1–11. http://dx.doi.org/10.1016/s1074-7613(00)80583-x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

Nur Çakmak, Fatma, Metin Erol, Pynar Ergül i Altan Yalçyner. "T lymphocytes and vitamins". Journal of Pediatrics 135, nr 4 (październik 1999): 531. http://dx.doi.org/10.1016/s0022-3476(99)70185-x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

Daugherty, Alan, i Debra L. Rateri. "T Lymphocytes in Atherosclerosis". Circulation Research 90, nr 10 (31.05.2002): 1039–40. http://dx.doi.org/10.1161/01.res.0000021397.28936.f9.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

Vallejo, Abbe N., Eduardo Davila, Cornelia M. Weyand i Jörg J. Goronzy. "Biology of T lymphocytes". Rheumatic Disease Clinics of North America 30, nr 1 (luty 2004): 135–57. http://dx.doi.org/10.1016/s0889-857x(03)00114-5.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

Prens, Errol, Reno Debets i Joost Hegmans. "T lymphocytes in psoriasis". Clinics in Dermatology 13, nr 2 (marzec 1995): 115–29. http://dx.doi.org/10.1016/0738-081x(95)93818-9.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Adibzadeh, M., E. Mariani, C. Bartoloni, I. Beckman, G. Ligthart, E. Remarque, S. Shall i in. "Lifespans of T lymphocytes". Mechanisms of Ageing and Development 91, nr 2 (październik 1996): 145–54. http://dx.doi.org/10.1016/0047-6374(96)01783-6.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

26

Nanno, Masanobu, Yutaka Kanamori, Hisashi Saito, Mariko Kawaguchi-Miyashita, Shin-ichiro Shimada i Hiromichi Ishikawa. "Intestinal Intraepithelial T Lymphocytes". Immunologic Research 18, nr 1 (sierpień 1998): 41–53. http://dx.doi.org/10.1007/bf02786512.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

27

Kabelitz, Dieter. "Human γδ T Lymphocytes". International Archives of Allergy and Immunology 102, nr 1 (1993): 1–9. http://dx.doi.org/10.1159/000236544.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

28

Globerson, Amiela. "T Lymphocytes and Aging". International Archives of Allergy and Immunology 107, nr 4 (1995): 491–97. http://dx.doi.org/10.1159/000237091.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

KABELITZ, D., W. R. HERZOG, B. ZANKER i H. WAGNER. "Human Cytotoxic T Lymphocytes." Scandinavian Journal of Immunology 22, nr 3 (wrzesień 1985): 329–35. http://dx.doi.org/10.1111/j.1365-3083.1985.tb01888.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

30

BERGSTROM, S. E., D. HAUZENBERGER i K. G. SUNDQVIST. "T Lymphocytes Degrade Fibronectin". Scandinavian Journal of Immunology 33, nr 4 (kwiecień 1991): 453–59. http://dx.doi.org/10.1111/j.1365-3083.1991.tb01794.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Guy-Grand, Delphine, i Pierre Vassalli. "Gut intraepithelial T lymphocytes". Current Opinion in Immunology 5, nr 2 (styczeń 1993): 247–52. http://dx.doi.org/10.1016/0952-7915(93)90012-h.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

Kononova, T. E., O. I. Urazova, V. V. Novitskii i P. A. Zakharova. "CYTOKINE-SECRETORY ACTIVITY OF T-LYMPHOCYTES-HELPERS 17 AND T-LYMPHOCYTES-HELPERS 1 / T-LYMPHOCYTES-HELPERS 17 IN PULMONARY TUBERCULOSIS". Siberian Medical Review, nr 6 (2017): 57–62. http://dx.doi.org/10.20333/2500136-2017-6-57-62.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

Dietl, Johannes, Hans-Peter Horny, Peter Ruck, Klaus Marzusch, Edwin Kaiserling, Henrik Griesser i Dieter Kabelitz. "Intradecidual T lymphocytes lack T-cell receptors". American Journal of Obstetrics and Gynecology 164, nr 2 (luty 1991): 702. http://dx.doi.org/10.1016/s0002-9378(11)80055-4.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

Kinoshita, K., T. Amagasaki, S. Ikeda, J. Suzuyama, K. Toriya, K. Nishino, M. Tagawa, M. Ichimaru, S. Kamihira i Y. Yamada. "Preleukemic state of adult T cell leukemia: abnormal T lymphocytosis induced by human adult T cell leukemia-lymphoma virus". Blood 66, nr 1 (1.07.1985): 120–27. http://dx.doi.org/10.1182/blood.v66.1.120.120.

Pełny tekst źródła

Streszczenie:

Abstract We report the clinical, hematologic, and immunologic features of 18 preleukemic adult T cell leukemia (pre-ATL) cases with abnormal T lymphocytosis induced by human adult T cell leukemia-lymphoma virus (HTLV/ATLV). The patients were from the Nagasaki district, which is one of the most endemic areas of ATL in Japan. Pre-ATL is a subclinical T cell abnormality differing from ATL. It is characterized by an insidious onset and appearance of abnormal T lymphocytes (10% to 40%) in the peripheral blood without clinical symptoms except for a few cases transiently presenting fever, skin eruptions, and slight lymphadenopathies. Most abnormal T lymphocytes were small and mature with incised or lobulated nuclei and formed E rosettes with sheep RBCs. Virologic and biomolecular analysis revealed that all cases were infected with HTLV, and proviral DNA was integrated in host lymphocytes from 12 of the 14 cases examined. Furthermore, the lymphocyte populations, including abnormal T lymphocytes, were monoclonal with respect to the site of the provirus integration. Abnormal T lymphocytosis persisted from one to more than seven years in six cases, three of which developed ATL after a one- to five-year pre-ATL stage, whereas abnormal T lymphocytes spontaneously decreased in the other seven patients. However, HTLV-infected monoclonal lymphocytes were detected in four cases examined, even after most of the abnormal T lymphocytes had disappeared. Moreover, the same clonally provirus- integrated lymphocytes persisted in two of four cases not only during the course of abnormal lymphocytosis, but also in the subsequent almost- normal blood. These results indicate that the majority of the cases were in a pre-ATL state with a potential to develop ATL.

Style APA, Harvard, Vancouver, ISO itp.

35

Kinoshita, K., T. Amagasaki, S. Ikeda, J. Suzuyama, K. Toriya, K. Nishino, M. Tagawa, M. Ichimaru, S. Kamihira i Y. Yamada. "Preleukemic state of adult T cell leukemia: abnormal T lymphocytosis induced by human adult T cell leukemia-lymphoma virus". Blood 66, nr 1 (1.07.1985): 120–27. http://dx.doi.org/10.1182/blood.v66.1.120.bloodjournal661120.

Pełny tekst źródła

Streszczenie:

We report the clinical, hematologic, and immunologic features of 18 preleukemic adult T cell leukemia (pre-ATL) cases with abnormal T lymphocytosis induced by human adult T cell leukemia-lymphoma virus (HTLV/ATLV). The patients were from the Nagasaki district, which is one of the most endemic areas of ATL in Japan. Pre-ATL is a subclinical T cell abnormality differing from ATL. It is characterized by an insidious onset and appearance of abnormal T lymphocytes (10% to 40%) in the peripheral blood without clinical symptoms except for a few cases transiently presenting fever, skin eruptions, and slight lymphadenopathies. Most abnormal T lymphocytes were small and mature with incised or lobulated nuclei and formed E rosettes with sheep RBCs. Virologic and biomolecular analysis revealed that all cases were infected with HTLV, and proviral DNA was integrated in host lymphocytes from 12 of the 14 cases examined. Furthermore, the lymphocyte populations, including abnormal T lymphocytes, were monoclonal with respect to the site of the provirus integration. Abnormal T lymphocytosis persisted from one to more than seven years in six cases, three of which developed ATL after a one- to five-year pre-ATL stage, whereas abnormal T lymphocytes spontaneously decreased in the other seven patients. However, HTLV-infected monoclonal lymphocytes were detected in four cases examined, even after most of the abnormal T lymphocytes had disappeared. Moreover, the same clonally provirus- integrated lymphocytes persisted in two of four cases not only during the course of abnormal lymphocytosis, but also in the subsequent almost- normal blood. These results indicate that the majority of the cases were in a pre-ATL state with a potential to develop ATL.

Style APA, Harvard, Vancouver, ISO itp.

36

Vianna-Jorge, Rosane, i Guilherme Suarez-Kurtz. "Potassium Channels in T Lymphocytes". BioDrugs 18, nr 5 (2004): 329–41. http://dx.doi.org/10.2165/00063030-200418050-00005.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

37

Guse, Andreas H. "Ca2+ Signaling in T-Lymphocytes". Critical Reviews™ in Immunology 18, nr 5 (1998): 419–48. http://dx.doi.org/10.1615/critrevimmunol.v18.i5.20.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

38

Jandrić-Kočić, Marijana. "Recirculation of naive T lymphocytes". Medicinski glasnik Specijalne bolnice za bolesti štitaste žlezde i bolesti metabolizma 27, nr 86 (2022): 25–48. http://dx.doi.org/10.5937/mgiszm2286025j.

Pełny tekst źródła

Streszczenie:

After development in the thymus, naive T lymphocytes come into circulation and continuously recirculate between the blood and peripheral lymphoid organs for activation and transformation into effector cells. The movement of naive T lymphocytes represents an ordered sequence controlled by the expression of specific of specific proteins (selectin, integrin and chemokine) that includes the recruitment of circulating lymphocytes on the luminal surface of the blood vessel, transendothelial transition and migration within the extravascular compartment of peripheral lymphoid organs. The question of the movement of naive T lymphocytes in and out of non-lymphoid organs in physiological conditions has not been fully resolved. There is an opinion that naive T lymphocytes under physiological conditions routinely access almost all non-lymphoid organs for the purpose of immunosurveillance and/or tolerance induction. Non-lymphoid organs burdened by chronic inflammation and tumor processes may possess a significant number of naive T lymphocytes. Organized lymphoid tissue causally contributes to the persistence of certain autoimmune diseases. Recruitment in tumor tissue and subsequent antitumor immune response correspond with a positive prognosis.

Style APA, Harvard, Vancouver, ISO itp.

39

Bockenstedt, Linda K., Mark A. Goldsmith, Gary A. Koretzky i Arthur Weiss. "The Activation of T Lymphocytes". Rheumatic Disease Clinics of North America 13, nr 3 (grudzień 1987): 411–30. http://dx.doi.org/10.1016/s0889-857x(21)00926-1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

40

Krensky, Alan M., i Carol Clayberger. "MHC-Unrestricted cytolytic T lymphocytes". Survey of Immunologic Research 4, nr 4 (grudzień 1985): 297–302. http://dx.doi.org/10.1007/bf02918737.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

41

Rowe-Pirra, William. "Comment s’épuisent les lymphocytes T". Pour la Science N° 530 – décembre, nr 12 (29.11.2021): 12. http://dx.doi.org/10.3917/pls.530.0012.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

Arokiaraj, M. C., i E. Menesson. "Rose treatment on T lymphocytes". Atherosclerosis 331 (sierpień 2021): e81. http://dx.doi.org/10.1016/j.atherosclerosis.2021.06.238.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

Kay, A. B., i S. R. Durham. "T-lymphocytes, allergy and asthma". Clinical Experimental Allergy 21, s1 (maj 1991): 17–21. http://dx.doi.org/10.1111/j.1365-2222.1991.tb01700.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Sheibak, V. M., i A. Y. Pauliukavets. "Biochemical heterogeneity of T-lymphocytes". Vestnik of Vitebsk State Medical University 17, nr 6 (29.11.2018): 7–17. http://dx.doi.org/10.22263/2312-4156.2018.6.7.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

Martinez, Olivia M. "Immunobiology of CD30+ T Lymphocytes". Graft 4, nr 3 (kwiecień 2001): 180–87. http://dx.doi.org/10.1177/152216280100400302.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

Dotti, Gianpietro. "T Lymphocytes Are Not Immune". Molecular Therapy 21, nr 6 (czerwiec 2013): 1114–15. http://dx.doi.org/10.1038/mt.2013.102.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

VON BOEHMER, HARALD, HORST BLUETHMANN, UWE STAERZ, MICHAEL STEINMETZ i PAWEL KISIELOW. "Developmental Biology of T Lymphocytes." Annals of the New York Academy of Sciences 546, nr 1 Molecular Bas (grudzień 1988): 104–8. http://dx.doi.org/10.1111/j.1749-6632.1988.tb21624.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

van Oosterhout, A. J. M. "Regulatory T-lymphocytes in asthma". European Respiratory Journal 26, nr 5 (1.11.2005): 918–32. http://dx.doi.org/10.1183/09031936.05.00011205.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

49

BERETTA, LAURA. "TRANSLATIONAL CONTROL IN T LYMPHOCYTES". International Reviews of Immunology 23, nr 3-4 (styczeń 2004): 347–63. http://dx.doi.org/10.1080/08830180490452549.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

50

Vié, H., i B. Clémenceau. "Transfert adoptif de lymphocytes T". Transfusion Clinique et Biologique 24, nr 3 (wrzesień 2017): 256–62. http://dx.doi.org/10.1016/j.tracli.2017.05.018.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!